COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 14th April 2020. As a result, our offices will now be closed till 14th April 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Article view: 490

Article download: 205

IP Indian Journal of Immunology and Respiratory Medicine

Evaluating the use of magnesium sulphate intravenous for the Asthma in pediatric patients

Full Text PDF Share on Facebook Share on Twitter

Author Details : Gunjan Pareshkumar Upadhyay, Pradipkumar Hirji Damor

Volume : 3, Issue : 2, Year : 2018

Article Page : 61-63

Suggest article by email


Background: One of the proposed mechanisms for the action of the magnesium sulphate includes relaxation of the bronchial smooth muscle by the inhibition of the calcium across the smooth muscle membranes. The present study was conducted to investigate the safety and efficacy of magnesium sulphate administration for the severity of acute asthma in pediatric patients.
Methodology: The present retrospective study was conducted at Department of Tuberculosis and Reparatory Medicine, GMERS Medical College, Gandhinagar, Gujarat. Inclusion criteria included the patients under the age of 18 years or younger and who were treated with intravenous magnesium sulphate for the treatment of asthma attacks in the department of emergency of the hospital. Data collection form was used to assess the details of the patients.
Results: Total of 60 paediatric patients were included in the present study. All the paediatric patients did received the magnesium sulphate through intravenous administration. Total of 40 patients required a PICU admission after the magnesium sulphate treatment. It was found that total of 96% of the patient did required the hospital admission. Around 5 patients were discharged directly from the emergency department. The serum concentrations of the magnesium sulphate were slight above the normal range that is 1.5 to 2.5 mg/dl.
Conclusions: Monitoring of the intravenous magnesium sulphate and the related practised in various medical institutions did vary. Further studies are required to determine the regimen of the dose of intravenous magnesium sulphate for the paediatric patients.

Keywords: Asthma; Intravenous; Magnesium sulphate; Paediatric patients.

Doi : 10.18231/2581-4222.2018.0017

How to cite : Upadhyay G P, Damor P H, Evaluating the use of magnesium sulphate intravenous for the Asthma in pediatric patients. IP Indian J Immunol Respir Med 2018;3(2):61-63

Copyright © 2018 by author(s) and IP Indian J Immunol Respir Med. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) (